For the first time, a one-time treatment has shown the ability to slow Huntington’s decline — including dementia symptoms — over three years.
The first 3D-printed brain tissue that can grow and function like typical brain tissue is a major breakthrough for scientists in search of an Alzheimer’s cure.
Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sample. In other words, this blood test can diagnose Alzheimer’s.
A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
Scientists at Oregon’s only public academic health center (OHSU) have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia.
Tau PET is an imaging test used to detect the presence of tau protein in the brain. Researchers say it’s the best way to predict the rate of cognitive decline due to Alzheimer’s.
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
A simple voice-based AI companion is offering gentle conversation and emotional support for people living with Alzheimer’s and dementia — no apps, no screens, and no tech skills required.
A twice-daily pill called ALZ-801 brings new hope to high-genetic-risk Alzheimer’s. Early findings suggest meaningful slowing of decline, stronger safety, and brain structure protection.
New research from the Framingham Heart Study shows that even mild hearing loss in midlife is linked to early signs of brain aging. The encouraging news: simple steps you take now may help protect memory, thinking skills, and long-term brain health.
It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.
